Jade Biosciences reported net income of -$56.08M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 24.41M | 12.29M | 24.41M | 24.42M | 24.51M | 24.72M | 24.82M | 27.60M | 27.65M | 27.76M | 27.90M | 28.85M | 28.87M | 27.76M | 28.99M | 32.63M | 32.63M | 57.79M | 49.35M | 63.56M | |||||
| Operating items | |||||||||||||||||||||||||
| Research & DevelopmentR&D | 3.42M | 5.05M | 7.25M | 8.36M | 10.78M | 12.22M | 13.49M | 16.03M | 16.88M | 17.81M | 20.08M | 21.25M | 13.66M | 31.23M | 20.02M | 22.55M | 22.01M | 1.50M | 36.05M | 50.06M | |||||
| Wages, Salaries and OtherWages | 0.51M | 1.88M | 2.25M | 1.71M | 3.12M | 3.58M | 4.43M | 5.30M | 5.69M | ||||||||||||||||
| Selling, General & AdministrativeSG&A | 2.78M | 3.22M | 3.76M | 3.85M | 3.37M | 3.63M | 4.15M | 4.30M | 4.48M | 4.25M | 4.54M | 4.92M | 1.90M | 4.30M | 3.36M | 5.23M | 5.39M | 6.44M | 7.39M | 8.85M | |||||
| Restructuring CostsRestructuring | 0.18M | ||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -0.18M | 27.04M | |||||||||||||||||||||||
| Operating ExpensesOpex | 6.20M | 8.27M | 11.02M | 12.21M | 14.15M | 15.85M | 17.64M | 20.34M | 21.37M | 22.07M | 24.62M | 26.16M | 15.55M | 35.54M | 23.38M | 27.78M | 27.40M | 34.98M | 43.45M | 58.92M | |||||
| Operating IncomeOp. Inc | -6.20M | -8.27M | -11.02M | -12.21M | -14.15M | -15.85M | -17.64M | -20.34M | -21.37M | -22.07M | -24.62M | -26.16M | -14.96M | -35.54M | -23.38M | -27.78M | -27.40M | -34.98M | -43.45M | -58.92M | |||||
| EBIT | -6.20M | -8.27M | -11.02M | -12.21M | -14.15M | -15.85M | -17.64M | -20.34M | -21.37M | -22.07M | -24.62M | -26.16M | -14.96M | -35.54M | -23.38M | -27.78M | -27.40M | -34.98M | -43.45M | -58.92M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | |||||||||||||||||||
| Non Operating Investment Income | 0.04M | ||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.05M | 0.11M | 0.23M | 0.56M | 0.93M | 1.12M | 1.31M | 1.80M | 1.71M | 1.44M | 1.40M | 0.39M | 1.16M | 0.61M | 1.83M | 2.25M | 3.08M | 3.10M | 3.23M | |||||
| Other Non Operating IncomeOther Non Op Inc. | 0.02M | 0.07M | 0.11M | -0.01M | 0.00M | 1.75M | 1.12M | 1.31M | 0.00M | 0.42M | -0.00M | 1.39M | 0.04M | -0.03M | 0.09M | -0.01M | -0.06M | ||||||||
| Non Operating IncomeNon Op. Inc. | 0.02M | 0.11M | 0.22M | 0.56M | 1.12M | 1.31M | 1.80M | 1.71M | 1.43M | -1.31M | -11.44M | -14.79M | -4.36M | 2.23M | 3.10M | 3.09M | 3.17M | ||||||||
| Net income details | |||||||||||||||||||||||||
| EBT | -6.18M | -8.22M | -10.91M | -11.99M | -13.59M | -14.92M | -16.52M | -19.02M | -19.56M | -20.36M | -23.19M | -24.77M | -14.58M | -46.98M | -38.17M | -32.13M | -25.15M | -31.89M | -40.35M | -55.75M | |||||
| Tax ProvisionsTaxes | -9.87M | 0.10M | 0.01M | ||||||||||||||||||||||
| Profit After TaxPAT | -6.18M | -8.28M | -11.49M | -12.13M | -13.59M | -14.72M | -16.52M | -19.05M | -19.59M | -20.41M | -23.46M | -24.82M | -16.87M | -46.98M | -38.17M | -32.16M | -25.18M | -31.93M | -40.84M | -56.08M | |||||
| Income from Continuing OperationsIncome (Continuing) | -6.18M | -8.22M | -10.91M | -11.99M | -13.59M | -14.92M | -16.52M | -19.02M | -19.56M | -20.36M | -23.19M | -24.77M | -14.58M | -37.11M | -38.17M | -32.13M | -25.15M | -31.89M | -40.45M | -55.77M | |||||
| Consolidated Net IncomeConsol Net Inc. | -6.18M | -8.22M | -10.91M | -11.99M | -13.59M | -14.92M | -16.52M | -19.02M | -19.56M | -20.36M | -23.19M | -24.77M | -14.58M | -37.11M | -38.17M | -32.13M | -25.15M | -31.89M | -40.45M | -55.77M | |||||
| Income towards Parent CompanyParent Net Inc | -6.18M | -8.22M | -10.91M | -11.99M | -13.59M | -14.92M | -16.52M | -19.02M | -19.56M | -20.36M | -23.19M | -24.77M | -14.58M | -37.11M | -38.17M | -32.13M | -25.15M | -31.89M | -40.45M | -55.77M | |||||
| Net Income towards Common StockholdersNet Income | -6.18M | -8.22M | -10.91M | -11.99M | -13.59M | -14.92M | -16.52M | -19.02M | -19.56M | -20.36M | -23.19M | -24.77M | -14.58M | -37.11M | -38.17M | -32.13M | -25.15M | -31.89M | -40.45M | -55.77M | |||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | -0.26 | -0.67 | -0.45 | -0.49 | -0.56 | -0.61 | -0.67 | -0.76 | -0.71 | -0.77 | -0.83 | -0.86 | -0.51 | -1.30 | -1.32 | -1.13 | -0.64 | -1.02 | -0.70 | -0.91 | |||||
| EPS (Diluted) | -0.26 | -0.67 | -0.45 | -0.49 | -0.56 | -0.61 | -0.67 | -0.76 | -0.71 | -0.77 | -0.83 | -0.86 | -0.51 | -1.30 | -1.32 | -1.13 | -0.64 | -1.02 | -0.70 | -0.91 | |||||
| Shares Outstanding | 23.89M | 12.29M | 24.41M | 24.41M | 24.45M | 24.47M | 24.78M | 25.17M | 27.64M | 26.33M | 27.80M | 28.76M | 28.86M | 28.58M | 28.99M | 28.45M | 39.58M | 31.36M | 57.80M | 61.08M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 23.89M | 12.29M | 24.41M | 24.41M | 24.45M | 24.47M | 24.78M | 25.17M | 27.64M | 26.33M | 27.80M | 28.76M | 28.86M | 28.58M | 28.99M | 28.45M | 39.58M | 31.36M | 57.80M | 61.08M | |||||
| EBITDA | -6.20M | -8.27M | -11.02M | -12.21M | -14.15M | -15.85M | -17.64M | -20.34M | -21.37M | -22.07M | -24.62M | -26.16M | -14.96M | -35.54M | -23.38M | -27.78M | -27.40M | -34.98M | -43.45M | -58.92M | |||||
| Interest ExpensesInt Expense | -0.00M | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | |||||||||||||||||||
| Tax Rate | 21.00 | -0.25 | -0.03 |